{
  "id": "f7f714dd4dcc5e03",
  "title": "Lyell Immunopharma Announces Initiation of Patient Dosing in First - of - Its - Kind Phase 3 Head - To - Head CAR T - Cell Clinical Trial in Aggressive Large B - Cell Lymphoma",
  "description": "20260212T133000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/12/tmt-newswire/globenewswire/lyell-immunopharma-announces-initiation-of-patient-dosing-in-first-of-its-kind-phase-3-head-to-head-car-t-cell-clinical-trial-in-aggressive-large-b-cell-lymphoma/2277096",
  "published_at": "20260212T133000Z",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/12/tmt-newswire/globenewswire/lyell-immunopharma-announces-initiation-of-patient-dosing-in-first-of-its-kind-phase-3-head-to-head-car-t-cell-clinical-trial-in-aggressive-large-b-cell-lymphoma/2277096",
    "url_mobile": "https://www.manilatimes.net/2026/02/12/tmt-newswire/globenewswire/lyell-immunopharma-announces-initiation-of-patient-dosing-in-first-of-its-kind-phase-3-head-to-head-car-t-cell-clinical-trial-in-aggressive-large-b-cell-lymphoma/2277096/amp",
    "title": "Lyell Immunopharma Announces Initiation of Patient Dosing in First - of - Its - Kind Phase 3 Head - To - Head CAR T - Cell Clinical Trial in Aggressive Large B - Cell Lymphoma",
    "seendate": "20260212T133000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/12/935566.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}